Ruxolitinib in Estrogen Receptor Positive Breast Cancer

计划入组 25 人 · 首次发布于 2012 年 5 月 9 日

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

计划入组 10 人 · 首次发布于 2016 年 4 月 27 日

Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

计划入组 33 人 · 首次发布于 2018 年 6 月 29 日

Tamoxifen(Soltamox)

C₂₆H₂₉NO · Rx

Fluoroestradiol F-18

C₁₈H₂₃FO₂

selective estrogen receptor degraders

Arvinas Estrogen Receptor, Inc.

United States

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

Breakthrough Strategy Overcomes Immunotherapy Resistance in Estrogen Receptor-Positive Breast Cancer

ImmuneOnco's IMM27M Shows Promise in Phase I Breast Cancer Trial, Advancing to Phase II

Mayo Clinic and Bon Secours Lead Evangeline Trial Testing (Z)-Endoxifen for Premenopausal Breast Cancer